January/February 2017 - Volume 40 - Issue 1 - Contributor Index

Alphabetical Search
E
H
O
Q
X

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid

Galán Sánchez-Seco, Victoria; Casanova-Peño, Ignacio; Álvarez-Lafuente, Roberto; More

Clinical Neuropharmacology . 40(1):29-33, January/February 2017.

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid

Galán Sánchez-Seco, Victoria; Casanova-Peño, Ignacio; Álvarez-Lafuente, Roberto; More

Clinical Neuropharmacology . 40(1):29-33, January/February 2017.

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid

Galán Sánchez-Seco, Victoria; Casanova-Peño, Ignacio; Álvarez-Lafuente, Roberto; More

Clinical Neuropharmacology . 40(1):29-33, January/February 2017.

Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease...

Rossi, Carlo; Genovesi, Dario; Marzullo, Paolo; More

Clinical Neuropharmacology . 40(1):34-36, January/February 2017.

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid

Galán Sánchez-Seco, Victoria; Casanova-Peño, Ignacio; Álvarez-Lafuente, Roberto; More

Clinical Neuropharmacology . 40(1):29-33, January/February 2017.

Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease...

Rossi, Carlo; Genovesi, Dario; Marzullo, Paolo; More

Clinical Neuropharmacology . 40(1):34-36, January/February 2017.

Switching L-dopa Therapy from Pulsatile to Pulse Administration Reduces Motor Complications in Parkinson's Disease

Mostile, Giovanni; Nicoletti, Alessandra; Dibilio, Valeria; More

Clinical Neuropharmacology . 40(1):6-10, January/February 2017.

Switching L-dopa Therapy from Pulsatile to Pulse Administration Reduces Motor Complications in Parkinson's Disease

Mostile, Giovanni; Nicoletti, Alessandra; Dibilio, Valeria; More

Clinical Neuropharmacology . 40(1):6-10, January/February 2017.

Efficacy of the Treatments Used in Multiple Sclerosis: From Meta-analysis to Number Needed to Treat

García-Ruiz, Antonio J.; Izquierdo-Ayuso, Guillermo; Navarro-Mascarell, Guillermo; More

Clinical Neuropharmacology . 40(1):37-42, January/February 2017.

Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease...

Rossi, Carlo; Genovesi, Dario; Marzullo, Paolo; More

Clinical Neuropharmacology . 40(1):34-36, January/February 2017.

Switching L-dopa Therapy from Pulsatile to Pulse Administration Reduces Motor Complications in Parkinson's Disease

Mostile, Giovanni; Nicoletti, Alessandra; Dibilio, Valeria; More

Clinical Neuropharmacology . 40(1):6-10, January/February 2017.

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid

Galán Sánchez-Seco, Victoria; Casanova-Peño, Ignacio; Álvarez-Lafuente, Roberto; More

Clinical Neuropharmacology . 40(1):29-33, January/February 2017.

Switching L-dopa Therapy from Pulsatile to Pulse Administration Reduces Motor Complications in Parkinson's Disease

Mostile, Giovanni; Nicoletti, Alessandra; Dibilio, Valeria; More

Clinical Neuropharmacology . 40(1):6-10, January/February 2017.

Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease...

Rossi, Carlo; Genovesi, Dario; Marzullo, Paolo; More

Clinical Neuropharmacology . 40(1):34-36, January/February 2017.

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid

Galán Sánchez-Seco, Victoria; Casanova-Peño, Ignacio; Álvarez-Lafuente, Roberto; More

Clinical Neuropharmacology . 40(1):29-33, January/February 2017.

Efficacy of the Treatments Used in Multiple Sclerosis: From Meta-analysis to Number Needed to Treat

García-Ruiz, Antonio J.; Izquierdo-Ayuso, Guillermo; Navarro-Mascarell, Guillermo; More

Clinical Neuropharmacology . 40(1):37-42, January/February 2017.

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid

Galán Sánchez-Seco, Victoria; Casanova-Peño, Ignacio; Álvarez-Lafuente, Roberto; More

Clinical Neuropharmacology . 40(1):29-33, January/February 2017.

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid

Galán Sánchez-Seco, Victoria; Casanova-Peño, Ignacio; Álvarez-Lafuente, Roberto; More

Clinical Neuropharmacology . 40(1):29-33, January/February 2017.

Efficacy of the Treatments Used in Multiple Sclerosis: From Meta-analysis to Number Needed to Treat

García-Ruiz, Antonio J.; Izquierdo-Ayuso, Guillermo; Navarro-Mascarell, Guillermo; More

Clinical Neuropharmacology . 40(1):37-42, January/February 2017.

Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease...

Rossi, Carlo; Genovesi, Dario; Marzullo, Paolo; More

Clinical Neuropharmacology . 40(1):34-36, January/February 2017.

Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease...

Rossi, Carlo; Genovesi, Dario; Marzullo, Paolo; More

Clinical Neuropharmacology . 40(1):34-36, January/February 2017.

Efficacy of the Treatments Used in Multiple Sclerosis: From Meta-analysis to Number Needed to Treat

García-Ruiz, Antonio J.; Izquierdo-Ayuso, Guillermo; Navarro-Mascarell, Guillermo; More

Clinical Neuropharmacology . 40(1):37-42, January/February 2017.

Efficacy of the Treatments Used in Multiple Sclerosis: From Meta-analysis to Number Needed to Treat

García-Ruiz, Antonio J.; Izquierdo-Ayuso, Guillermo; Navarro-Mascarell, Guillermo; More

Clinical Neuropharmacology . 40(1):37-42, January/February 2017.

Author:
Kodesh, Arad MD

Switching L-dopa Therapy from Pulsatile to Pulse Administration Reduces Motor Complications in Parkinson's Disease

Mostile, Giovanni; Nicoletti, Alessandra; Dibilio, Valeria; More

Clinical Neuropharmacology . 40(1):6-10, January/February 2017.

Efficacy of the Treatments Used in Multiple Sclerosis: From Meta-analysis to Number Needed to Treat

García-Ruiz, Antonio J.; Izquierdo-Ayuso, Guillermo; Navarro-Mascarell, Guillermo; More

Clinical Neuropharmacology . 40(1):37-42, January/February 2017.

Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease...

Rossi, Carlo; Genovesi, Dario; Marzullo, Paolo; More

Clinical Neuropharmacology . 40(1):34-36, January/February 2017.

Efficacy of the Treatments Used in Multiple Sclerosis: From Meta-analysis to Number Needed to Treat

García-Ruiz, Antonio J.; Izquierdo-Ayuso, Guillermo; Navarro-Mascarell, Guillermo; More

Clinical Neuropharmacology . 40(1):37-42, January/February 2017.

Switching L-dopa Therapy from Pulsatile to Pulse Administration Reduces Motor Complications in Parkinson's Disease

Mostile, Giovanni; Nicoletti, Alessandra; Dibilio, Valeria; More

Clinical Neuropharmacology . 40(1):6-10, January/February 2017.

Efficacy of the Treatments Used in Multiple Sclerosis: From Meta-analysis to Number Needed to Treat

García-Ruiz, Antonio J.; Izquierdo-Ayuso, Guillermo; Navarro-Mascarell, Guillermo; More

Clinical Neuropharmacology . 40(1):37-42, January/February 2017.

Switching L-dopa Therapy from Pulsatile to Pulse Administration Reduces Motor Complications in Parkinson's Disease

Mostile, Giovanni; Nicoletti, Alessandra; Dibilio, Valeria; More

Clinical Neuropharmacology . 40(1):6-10, January/February 2017.

Switching L-dopa Therapy from Pulsatile to Pulse Administration Reduces Motor Complications in Parkinson's Disease

Mostile, Giovanni; Nicoletti, Alessandra; Dibilio, Valeria; More

Clinical Neuropharmacology . 40(1):6-10, January/February 2017.

Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease...

Rossi, Carlo; Genovesi, Dario; Marzullo, Paolo; More

Clinical Neuropharmacology . 40(1):34-36, January/February 2017.

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid

Galán Sánchez-Seco, Victoria; Casanova-Peño, Ignacio; Álvarez-Lafuente, Roberto; More

Clinical Neuropharmacology . 40(1):29-33, January/February 2017.

Switching L-dopa Therapy from Pulsatile to Pulse Administration Reduces Motor Complications in Parkinson's Disease

Mostile, Giovanni; Nicoletti, Alessandra; Dibilio, Valeria; More

Clinical Neuropharmacology . 40(1):6-10, January/February 2017.

Author:
Talaei, Ali MD

Switching L-dopa Therapy from Pulsatile to Pulse Administration Reduces Motor Complications in Parkinson's Disease

Mostile, Giovanni; Nicoletti, Alessandra; Dibilio, Valeria; More

Clinical Neuropharmacology . 40(1):6-10, January/February 2017.

Author:
You, Yi-Ping MD

Switching L-dopa Therapy from Pulsatile to Pulse Administration Reduces Motor Complications in Parkinson's Disease

Mostile, Giovanni; Nicoletti, Alessandra; Dibilio, Valeria; More

Clinical Neuropharmacology . 40(1):6-10, January/February 2017.